{"name":"Kim, Seok Jin","slug":"kim-seok-jin","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"RB","genericName":"RB","slug":"rb","indication":"Deep vein thrombosis","status":"marketed"}]}],"pipeline":[{"name":"RB","genericName":"RB","slug":"rb","phase":"marketed","mechanism":"Rivaroxaban is an anticoagulant that works by inhibiting Factor Xa.","indications":["Deep vein thrombosis","Pulmonary embolism","Atrial fibrillation for stroke prevention","Acute coronary syndrome"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE40WWlPNEY1YnE3RHdXTTMxS0lvUnJqcWFVeHYxT1BEa1N5c3hiS25KVFpaaE43SzZrTzl2eEdJS194U1M4SS1RUi1ZUGVuekJNMGFLa0FpSzVESlhKc3pHeXNVZmdRajBCV2ZpMTRB0gFyQVVfeXFMT3dZUHA5Y0RSQkpEWE5aZWI1TE9lcjBSYWFoaEJvZVZCd2xhbzJOeU10Zk9IZnN2NEFiQVJQbjFsY2lTS0ZjYnNmNnFjMzFYWFBvaFM1S1Mxa2hMMEwzbGpMLUhyYndPVnduMWZZbWNaek9B?oc=5","date":"2026-04-08","type":"pipeline","source":"koreabiomed.com","summary":"Delayed access to new DLBCL drugs widens Korea-global treatment gap: experts - koreabiomed.com","headline":"Delayed access to new DLBCL drugs widens Korea-global treatment gap: experts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOTndvaUp6c3BvNlhNRFR5VUR3OGpUdHUwWjFWRDliaFk1ekg3SjFqajRjSWxZbWJELUxZLVNieG4wMUlneHVwdzlrN0duLUlvemJYVmJOdEt3OUJUR3FNQnIxQjhJMWlEY0t1dHY4OUZ0bnlwMWJJd0RaSzNZLTFyeXloUG1mZ3hTWV94eTB2RU9EbnJPQ19WZlhnRFZ2Wlg5RjNHaA?oc=5","date":"2026-04-01","type":"pipeline","source":"Seoul Economic Daily","summary":"Ildong Pharmaceutical Group Announces Executive Appointments - Seoul Economic Daily","headline":"Ildong Pharmaceutical Group Announces Executive Appointments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1fNEdoc1hNNDZSR1gwRFhQRkx3bFVTSW15QmtrNzVibTRRTVR6YXJHN1pMcWluOGEtSjAya1diVEJsbmxLQzdhdUczZGtxcXZ6a0xrV2k2NWZlck94Q2pBa2RsWVZ6UGRTR2RmcGxR0gFyQVVfeXFMUE5FNFphdTNaMWRsVnRzNmN1b01RMXJUMDFZVmxodGIycXBvU0NxaDVTNkg2dlNHYm5mMERaWnZIZE16bkpYOGN6SnB2OWFZN1czUDVzaG15MEl4V3N1V1l0bDhNa3l4Y1dnWDdFaHZfTFJB?oc=5","date":"2026-03-27","type":"trial","source":"koreabiomed.com","summary":"ImmunOncia reports phase 2 data for Danburstotug in NK/T-cell lymphoma - koreabiomed.com","headline":"ImmunOncia reports phase 2 data for Danburstotug in NK/T-cell lymphoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQSVE0LThTMUtyUWZxczhQNnR5ZlpPUU0ybEJwc1UtRDVPYzB3T1NHbHoyZm1fRVJqNE5RR1JTaUFEcGZLZGRJQ0JkUzV5cnZlNjM0N1pxejZzbmJiZ2FxZnY5NG83LWFkTTJyR3BvM051cnQyNV8tbW04NkZ2UXZiSdIBlAFBVV95cUxPZk1ubTd4UWtYaTlrNk9nUV8xWl93U3cxa2Y0Y1NCZmZhRnVRblc3dE5LckxZVDNHZlktQUFKVHgxeUJLbkpSZ2NiQzhLOTFsQ3FfV0JUR0w5ZE5hLTFzb1FmZFZzTWk0ZVJrdFl6TlJrODl5ZnhHd2k0aDh6cXZJOXk3LUxpRlg1NXVDdEIwQXJOUXd2?oc=5","date":"2026-03-16","type":"trial","source":"Chosunbiz","summary":"South Korea pushes generic price cuts as industry slams phase 3-only support - CHOSUNBIZ - Chosunbiz","headline":"South Korea pushes generic price cuts as industry slams phase 3-only support - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYTRmOVZXWFBUVVRTaTFjcGlUR0NnUzl3VWVNRjVtQUlJNW1rdWxrNnpqWHdFY2d1V3h0aGgzSVFGbXYzd2ZPQW9ORW44czkxR2MwWXV0VWZOUENGOTRIWlZMOXBaZnptRjJhM09LQ2hudnFLQkQtUjU5ZWtEWDFPUGo5aEdsalVq?oc=5","date":"2025-10-24","type":"pipeline","source":"조선일보","summary":"Kolon Group Appoints Kim Yeong-bom as Kolon Global CEO - 조선일보","headline":"Kolon Group Appoints Kim Yeong-bom as Kolon Global CEO - 조선일보","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE4tSW5yVVJ5V2lQMGRZREJ0cGtVVTlrOGJNeWY5Rkg5ZC1jM0kyN3hPWHE4TXpZSEhMVE9aQV9YMG5RU3BFZmg5a29pcndORlBtdGJPdUQ3d2ZBdl8tSU04RTI0NnhmelQyRDlqeHJB?oc=5","date":"2024-09-11","type":"pipeline","source":"KED Global","summary":"Celltrion earmarks billions of dollars to build CDMO plant: chairman - KED Global","headline":"Celltrion earmarks billions of dollars to build CDMO plant: chairman","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-08-16","type":"pipeline","source":"Telegraph India","summary":"BTS member Jin treks Mt. Hallasan in new reality show Run Jin post-military service - Telegraph India","headline":"BTS member Jin treks Mt. Hallasan in new reality show Run Jin post-military service","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE82RVREblRpQ2NGYlduV1ZNaDhqT2J1cVhGRkh1UkdzRXloQjg3SnF5MWthYVd4UF9jU2JEM1IxbnQtcmU0eFV2TWRzemw3UFM3Ujcw?oc=5","date":"2024-07-10","type":"pipeline","source":"매일경제","summary":"Hecto Healthcare, a subsidiary of Hecto Innovation, will enter the Chinese probiotic market worth 15.. - 매일경제","headline":"Hecto Healthcare, a subsidiary of Hecto Innovation, will enter the Chinese probiotic market worth 15.. - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9EUnZwbVZSTkl3c0RndHlNQzFQMFdnaHludlNBN0xoQ21sWEpHdldOQUxQR2lxREJQYXBZWUY5Z052WmljTDFYT3JZUi15eWFoVWwzZTd1R3JrWTh5Vng2Ql9rVTE2dzAzNFdZcDRB0gFyQVVfeXFMTmZvXzRYQXFURTU5RUJDWl9PemRFQmlORmFHNmpldUY1THh2ZjRyVGdmcktKR00wT2dvRjhSSFR5bWRQdk5EVUpZZWM4MEVFM2Y4Q3MtSXQzYmlnYjZPemVIYzRFZi13azA4d1dLdkowQWFn?oc=5","date":"2024-05-08","type":"pipeline","source":"koreabiomed.com","summary":"Sobi-Handok joint venture raises expectations about Kineret launch in Korea - koreabiomed.com","headline":"Sobi-Handok joint venture raises expectations about Kineret launch in Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5GWnJXNnNBQ3hvTTFLTkw4VVJ3MzZLZzUyU25DbkhDdHBmUFJLMTJKNGVWVjFWXzNTaEdWRDRMb2FVYVBiMW9pXzNmY0JTQlNSdlVMQkdZdGhoT0liSXRjOTZnNVVVaHdfVHdNdDhR?oc=5","date":"2024-01-11","type":"earnings","source":"KED Global","summary":"Celltrion revises up earnings goals to overtake Amgen - KED Global","headline":"Celltrion revises up earnings goals to overtake Amgen","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-12-28","type":"deal","source":"The Korea Times","summary":"Celltrion completes merger with sales unit as part of integration plan - The Korea Times","headline":"Celltrion completes merger with sales unit as part of integration plan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5mcF9FOFEzN2tvNmJSSFpoZUNxbWpsNEQzUFVjSExnNWdfaDhsdHFaeVBKZ2thRmlocy1SLXRET3JvbHlCb0xKa3U1VmFSZ0taMUJrNFdGekNVbVpoeWNnN09nQ1l4NTFmeUJCWHl3?oc=5","date":"2023-10-06","type":"pipeline","source":"KED Global","summary":"Ildong Pharma to spin off R&D subsidiary in Nov - KED Global","headline":"Ildong Pharma to spin off R&D subsidiary in Nov","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}